DataMeds AI, Inc.
MEDS- Exchange
- Nasdaq
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- SEC CIK
- 0002030763
No open-market purchases or sales by DataMeds AI, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $160.6K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +9 vs. previous quarter
- 9
- 13F valueReported value at the end of Q2 2026
- $160.6K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding MEDS, Q2 2026
No superinvestor reported holding MEDS at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by DataMeds AI, Inc. insiders from Form 4, newest first.
No open-market purchases or sales by DataMeds AI, Inc. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in DataMeds AI, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 20,532 | $63.6K | 0.00% | +20,532 | New |
| Geode Capital Management, LLC | 12,467 | $38.6K | 0.00% | +12,467 | New |
| Vanguard Capital Management LLC | 11,085 | $34.4K | 0.00% | +11,085 | New |
| Vanguard Fiduciary Trust Co | 6,191 | $19.2K | 0.00% | +6,191 | New |
| Barclays PLC | 723 | $2.24K | 0.00% | +723 | New |
| Tower Research Capital LLC (TRC) | 678 | $2.10K | 0.00% | +678 | New |
| Fortitude Family Office, LLC | 118 | $366 | 0.00% | +118 | New |
| Global Retirement Partners, LLC | 2 | $6 | 0.00% | +2 | New |
| Danske Bank A/S | 1 | $3 | 0.00% | +1 | New |